New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil

The use of already-approved drugs to treat new or alternative diseases has proved to be beneficial in medicine, because it reduces both drug development costs and timelines. Most drugs can be used to treat different illnesses, due their mechanisms of action are not restricted to one molecular target...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruz-Burgos, Marian, Losada-Garcia, Alberto, Cruz-Hernández, Carlos D., Cortés-Ramírez, Sergio A., Camacho-Arroyo, Ignacio, Gonzalez-Covarrubias, Vanessa, Morales-Pacheco, Miguel, Trujillo-Bornios, Samantha I., Rodríguez-Dorantes, Mauricio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952883/
https://www.ncbi.nlm.nih.gov/pubmed/33718200
http://dx.doi.org/10.3389/fonc.2021.627229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952883/
https://www.ncbi.nlm.nih.gov/pubmed/33718200
http://dx.doi.org/10.3389/fonc.2021.627229

Ejemplares similares